# Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study

> **NCT02876718** · — · COMPLETED · sponsor: **Bayer** · enrollment: 253 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Rivaroxaban (Xarelto, BAY 59-7939)

## Key facts

- **NCT ID:** NCT02876718
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-11
- **Primary completion:** 2018-01-09
- **Final completion:** 2018-01-09
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2018-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02876718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02876718, "Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02876718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*